主頁
限時動態
社團
粉絲專頁
市場
查閱更多
社團 粉絲專頁 市場 活動 文章 折扣 論壇 電影 遊戲 Merits
登錄 註冊
夜間模式
Targeted Therapies Revolutionize GIST Treatment, Driving High Pharmaceutical Revenue
The pharmaceutical revenue in the Gastrointestinal Stromal Tumors (GIST) Market is overwhelmingly dominated by Targeted Therapies, specifically the Tyrosine Kinase Inhibitors (TKIs). The dramatic success of Imatinib, the first agent approved for GIST, established a precedent for mutation-specific cancer treatment, fundamentally changing the disease from a death sentence to a manageable, chronic...
0 留言 ·0 分享 ·345 瀏覽次數 ·0 評論
請登入後按讚、分享和留言！
升級至高級
選擇適合您的方案
升級
MGBOX https://magicbox.mg